The polyG diseases: a new disease entity

Acta Neuropathol Commun. 2022 May 31;10(1):79. doi: 10.1186/s40478-022-01383-y.

Abstract

Recently, inspired by the similar clinical and pathological features shared with fragile X-associated tremor/ataxia syndrome (FXTAS), abnormal expansion of CGG repeats in the 5' untranslated region has been found in neuronal intranuclear inclusion disease (NIID), oculopharyngeal myopathy with leukoencephalopathy (OPML), and oculopharyngodistal myopathy (OPDMs). Although the upstream open reading frame has not been elucidated in OPML and OPDMs, polyglycine (polyG) translated by expanded CGG repeats is reported to be as a primary pathogenesis in FXTAS and NIID. Collectively, these findings indicate a new disease entity, the polyG diseases. In this review, we state the common clinical manifestations, pathological features, mechanisms, and potential therapies in these diseases, and provide preliminary opinions about future research in polyG diseases.

Keywords: Fragile X-associated tremor/ataxia syndrome; Neuronal intranuclear inclusion disease; Oculopharyngeal myopathy with leukoencephalopathy; Oculopharyngodistal myopathy; PolyG diseases.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ataxia / complications
  • Fragile X Mental Retardation Protein*
  • Fragile X Syndrome* / pathology
  • Humans
  • Intranuclear Inclusion Bodies
  • Muscular Dystrophies
  • Neurodegenerative Diseases
  • Peptides
  • Tremor

Substances

  • Peptides
  • Fragile X Mental Retardation Protein
  • polyglycine

Supplementary concepts

  • Fragile X Tremor Ataxia Syndrome
  • Neuronal intranuclear inclusion disease
  • Oculopharyngodistal Myopathy